Selected research
Industry Research
Angiopoietin 1 Receptor Industry Research Report 2026
Market perspective
The global Angiopoietin 1 Receptor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Angiopoietin 1 Receptor is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Angiopoietin 1 Receptor is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Angiopoietin 1 Receptor include Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., PharmAbcine, Inc., Exelixis, Inc., Eddingpharm, Deciphera Pharmaceuticals, LLC and Aerpio Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Angiopoietin 1 Receptor market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Angiopoietin 1 Receptor Market by Company
Teva Pharmaceutical Industries Ltd.
Sanofi
Pfizer Inc.
PharmAbcine, Inc.
Exelixis, Inc.
Eddingpharm
Deciphera Pharmaceuticals, LLC
Aerpio Therapeutics, Inc.
Angiopoietin 1 Receptor Segment by Type
AP-185
ARP-1536
MAN-01
PMC-001
Others
Angiopoietin 1 Receptor Segment by Application
Ureter Cancer
Neuroendocrine Tumors
Ovarian Cancer
Bladder Cancer
Others
Angiopoietin 1 Receptor Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiopoietin 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Angiopoietin 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiopoietin 1 Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Angiopoietin 1 Receptor manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Angiopoietin 1 Receptor by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Angiopoietin 1 Receptor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AP-185
- ARP-1536
- MAN-01
- PMC-001
- Others
Applications
- Ureter Cancer
- Neuroendocrine Tumors
- Ovarian Cancer
- Bladder Cancer
- Others
Companies covered
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- PharmAbcine, Inc.
- Exelixis, Inc.
- Eddingpharm
- Deciphera Pharmaceuticals, LLC
- Aerpio Therapeutics, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Angiopoietin 1 Receptor Market Size (2021-2032)
- 2.2.2 Global Angiopoietin 1 Receptor Sales (2021-2032)
- 2.2.3 Global Angiopoietin 1 Receptor Market Average Price (2021-2032)
- 2.3 Angiopoietin 1 Receptor by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 AP-185
- 2.3.3 ARP-1536
- 2.3.4 MAN-01
- 2.3.5 PMC-001
- 2.3.6 Others
- 2.4 Angiopoietin 1 Receptor by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ureter Cancer
- 2.4.3 Neuroendocrine Tumors
- 2.4.4 Ovarian Cancer
- 2.4.5 Bladder Cancer
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Angiopoietin 1 Receptor Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Angiopoietin 1 Receptor Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Angiopoietin 1 Receptor Revenue of Manufacturers (2021-2026)
- 3.4 Global Angiopoietin 1 Receptor Average Price by Manufacturers (2021-2026)
- 3.5 Global Angiopoietin 1 Receptor Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Angiopoietin 1 Receptor, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Angiopoietin 1 Receptor, Product Type & Application
- 3.8 Global Manufacturers of Angiopoietin 1 Receptor, Established Date
- 3.9 Global Angiopoietin 1 Receptor Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries Ltd.
- 4.1.1 Teva Pharmaceutical Industries Ltd. Company Information
- 4.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 4.1.3 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Angiopoietin 1 Receptor Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Pfizer Inc.
- 4.3.1 Pfizer Inc. Company Information
- 4.3.2 Pfizer Inc. Business Overview
- 4.3.3 Pfizer Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Inc. Angiopoietin 1 Receptor Product Portfolio
- 4.3.5 Pfizer Inc. Recent Developments
- 4.4 PharmAbcine, Inc.
- 4.4.1 PharmAbcine, Inc. Company Information
- 4.4.2 PharmAbcine, Inc. Business Overview
- 4.4.3 PharmAbcine, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PharmAbcine, Inc. Angiopoietin 1 Receptor Product Portfolio
- 4.4.5 PharmAbcine, Inc. Recent Developments
- 4.5 Exelixis, Inc.
- 4.5.1 Exelixis, Inc. Company Information
- 4.5.2 Exelixis, Inc. Business Overview
- 4.5.3 Exelixis, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Exelixis, Inc. Angiopoietin 1 Receptor Product Portfolio
- 4.5.5 Exelixis, Inc. Recent Developments
- 4.6 Eddingpharm
- 4.6.1 Eddingpharm Company Information
- 4.6.2 Eddingpharm Business Overview
- 4.6.3 Eddingpharm Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eddingpharm Angiopoietin 1 Receptor Product Portfolio
- 4.6.5 Eddingpharm Recent Developments
- 4.7 Deciphera Pharmaceuticals, LLC
- 4.7.1 Deciphera Pharmaceuticals, LLC Company Information
- 4.7.2 Deciphera Pharmaceuticals, LLC Business Overview
- 4.7.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Portfolio
- 4.7.5 Deciphera Pharmaceuticals, LLC Recent Developments
- 4.8 Aerpio Therapeutics, Inc.
- 4.8.1 Aerpio Therapeutics, Inc. Company Information
- 4.8.2 Aerpio Therapeutics, Inc. Business Overview
- 4.8.3 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Portfolio
- 4.8.5 Aerpio Therapeutics, Inc. Recent Developments
5 Global Angiopoietin 1 Receptor Market Scenario by Region
- 5.1 Global Angiopoietin 1 Receptor Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Angiopoietin 1 Receptor Sales by Region: 2021-2032
- 5.2.1 Global Angiopoietin 1 Receptor Sales by Region: 2021-2026
- 5.2.2 Global Angiopoietin 1 Receptor Sales by Region: 2027-2032
- 5.3 Global Angiopoietin 1 Receptor Revenue by Region: 2021-2032
- 5.3.1 Global Angiopoietin 1 Receptor Revenue by Region: 2021-2026
- 5.3.2 Global Angiopoietin 1 Receptor Revenue by Region: 2027-2032
- 5.4 North America Angiopoietin 1 Receptor Market Facts & Figures by Country
- 5.4.1 North America Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Angiopoietin 1 Receptor Sales by Country (2021-2032)
- 5.4.3 North America Angiopoietin 1 Receptor Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Angiopoietin 1 Receptor Market Facts & Figures by Country
- 5.5.1 Europe Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Angiopoietin 1 Receptor Sales by Country (2021-2032)
- 5.5.3 Europe Angiopoietin 1 Receptor Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Angiopoietin 1 Receptor Market Facts & Figures by Country
- 5.6.1 Asia Pacific Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Angiopoietin 1 Receptor Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Angiopoietin 1 Receptor Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Angiopoietin 1 Receptor Market Facts & Figures by Country
- 5.7.1 South America Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Angiopoietin 1 Receptor Sales by Country (2021-2032)
- 5.7.3 South America Angiopoietin 1 Receptor Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Angiopoietin 1 Receptor Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Angiopoietin 1 Receptor Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Angiopoietin 1 Receptor Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Angiopoietin 1 Receptor Sales by Type (2021-2032)
- 6.1.1 Global Angiopoietin 1 Receptor Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Angiopoietin 1 Receptor Sales Market Share by Type (2021-2032)
- 6.2 Global Angiopoietin 1 Receptor Revenue by Type (2021-2032)
- 6.2.1 Global Angiopoietin 1 Receptor Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Angiopoietin 1 Receptor Revenue Market Share by Type (2021-2032)
- 6.3 Global Angiopoietin 1 Receptor Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Angiopoietin 1 Receptor Sales by Application (2021-2032)
- 7.1.1 Global Angiopoietin 1 Receptor Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Angiopoietin 1 Receptor Sales Market Share by Application (2021-2032)
- 7.2 Global Angiopoietin 1 Receptor Revenue by Application (2021-2032)
- 7.2.1 Global Angiopoietin 1 Receptor Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Angiopoietin 1 Receptor Revenue Market Share by Application (2021-2032)
- 7.3 Global Angiopoietin 1 Receptor Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Angiopoietin 1 Receptor Value Chain Analysis
- 8.1.1 Angiopoietin 1 Receptor Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Angiopoietin 1 Receptor Production Mode & Process
- 8.2 Angiopoietin 1 Receptor Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Angiopoietin 1 Receptor Distributors
- 8.2.3 Angiopoietin 1 Receptor Customers
9 Global Angiopoietin 1 Receptor Analyzing Market Dynamics
- 9.1 Angiopoietin 1 Receptor Industry Trends
- 9.2 Angiopoietin 1 Receptor Industry Drivers
- 9.3 Angiopoietin 1 Receptor Industry Opportunities and Challenges
- 9.4 Angiopoietin 1 Receptor Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst